-+ 0.00%
-+ 0.00%
-+ 0.00%

Daxor Intends To Transition Regulatory Reporting Framework Requirement from Investment Company Act of 1940 To Securities Exchange Act of 1934

Benzinga·02/10/2026 13:09:05
Listen to the news

Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announced its intention to transition its primary regulatory reporting framework from the Investment Company Act of 1940 (the Investment Company Act) to the Securities Exchange Act of 1934 (the "Exchange Act"), subject to its completion of required regulatory filings and approvals. This transition reflects the sustained rapid scaling and strategic maturation of the Company's core diagnostic technology operating business.